4.7 Article

Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis

期刊

SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-021-86064-x

关键词

-

资金

  1. Danish Research Foundation [01-2016]

向作者/读者索取更多资源

The study compared blood CRPM levels in OA and RA patients, finding that while the average levels were lower in OA patients compared to RA patients, a significant subset of OA patients had high CRPM levels similar to RA. Furthermore, OA patients with high CRPM levels were more likely to develop contra-lateral knee OA over a two-year follow-up period.
The heterogeneous nature of osteoarthritis (OA) and the need to subtype patients is widely accepted in the field. The biomarker CRPM, a metabolite of C-reactive protein (CRP), is released to the circulation during inflammation. Blood CRPM levels have shown to be associated with disease activity and response to treatment in rheumatoid arthritis (RA). We investigated the level of blood CRPM in OA compared to RA using data from two phase III knee OA and two RA studies (N=1591). Moreover, the association between CRPM levels and radiographic progression was investigated. The mean CRPM levels were significantly lower in OA (8.5 [95% CI 8.3-8.8] ng/mL, n=781) compared to the RA patients (12.8 [9.5-16.0] ng/mL, n=60); however, a significant subset of OA patients (31%) had CRPM levels (>= 9 ng/mL) comparable to RA. Furthermore, OA patients (n=152) with CRPM levels >= 9 ng/mL were more likely to develop contra-lateral knee OA assessed by X-ray over a two-year follow-up period with an odds ratio of 2.2 [1.0-4.7]. These data suggest that CRPM is a blood-based biochemical marker for early identification OA patients with an inflammatory phenotype.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据